Clinical trial
A Trial to Assess the Efficacy and Safety of 400mg/Day Lacosamide in Subjects…
NCT00350103 · UCB Pharma, Industry · Completed
Key facts
| NCT number | NCT00350103 |
|---|---|
| Title | A Trial to Assess the Efficacy and Safety of 400mg/Day Lacosamide in Subjects With Painful Diabetic Neuropathy |
| Official title | A Multi-center, Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of 400mg/Day Lacosamide in Subjects With Painful Distal Diabetic Neuropathy Using Two Different Titration Schemes |
| Lead sponsor | UCB Pharma, Industry |
| Collaborators | SCHWARZ BIOSCIENCES GmbH - Part of UCB Group |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Painful Diabetic Neuropathy |
| Intervention type | Drug |
| Interventions | SPM 929, Placebo |
| Enrollment | 551 |
| Start date | Jun 30, 2006 |
| Primary completion | Jun 29, 2007 |
| Completion | Jun 29, 2007 |
| First posted | Jul 10, 2006 |
| Last update posted | Mar 22, 2024 |
| Countries | Germany |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: